Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 152Lymphoma, Mantle-Cell 30Lymphoma, Non-Hodgkin 22Lymphoma, Follicular 22Lymphoma 22Recurrence 21Neoplasms, Plasma Cell 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Leukemia, Myeloid, Acute 12Waldenstrom Macroglobulinemia 11Lymphoma, Large B-Cell, Diffuse 11Immunoglobulin Light-chain Amyloidosis 10Neoplasms 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Lymphocytic, Chronic, B-Cell 8Lymphoma, B-Cell 7Leukemia 6Carcinoma, Non-Small-Cell Lung 6Myelodysplastic Syndromes 5Hematologic Neoplasms 5Brain Neoplasms 5Amyloidosis 5Lymphoma, Large-Cell, Immunoblastic 4Hematologic Diseases 4Congenital Abnormalities 4Prostatic Neoplasms 3Paraproteinemias 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Erythroblastic, Acute 3

Interventions

pegaspargase 2Vincristine 2Methotrexate 2Cytarabine 2ruxolitinib 1palbociclib 1nelarabine 1Prednisone 1Prednisolone 1Panobinostat 1Mitoxantrone 1Mercaptopurine 1Hydrocortisone 1Etoposide 1Doxorubicin 1Dexamethasone 1Daclizumab 1Cyclophosphamide 1Clofarabine 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, T-Cell × Bortezomib × Clear all
NCT02518750 2019-04-03

Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma

St. Jude Children's Research Hospital

Phase 2 Terminated
3 enrolled 6 charts
LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Leukemia, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡